Synageva BioPharma (GEVA)

Add to Watchlists
Create an Alert
66.97 -1.81  -2.63% NASDAQ Oct 1, 2:14PM BATS Real time Currency in USD

Synageva BioPharma Price to Book Value:

3.962 for Oct. 1, 2014

View 4,000+ financial data types

View Full Chart

Synageva BioPharma Price to Book Value Chart

Export Data
Save Image

Synageva BioPharma Historical Price to Book Value Data

View and export this data going back to 1997. Start your Free Trial
Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Oct. 1, 2014 3.962
Sept. 30, 2014 4.069
Sept. 29, 2014 4.097
Sept. 26, 2014 4.029
Sept. 25, 2014 3.834
Sept. 24, 2014 3.892
Sept. 23, 2014 3.734
Sept. 22, 2014 3.713
Sept. 19, 2014 3.834
Sept. 18, 2014 3.820
Sept. 17, 2014 3.822
Sept. 16, 2014 3.835
Sept. 15, 2014 3.868
Sept. 12, 2014 4.051
Sept. 11, 2014 3.962
Sept. 10, 2014 3.903
Sept. 9, 2014 3.751
Sept. 8, 2014 3.841
Sept. 5, 2014 3.824
Sept. 4, 2014 3.903
Sept. 3, 2014 4.049
Sept. 2, 2014 4.118
Aug. 29, 2014 4.270
Aug. 28, 2014 4.267
Aug. 27, 2014 4.559
   
Aug. 26, 2014 4.554
Aug. 25, 2014 4.489
Aug. 22, 2014 4.251
Aug. 21, 2014 4.154
Aug. 20, 2014 4.272
Aug. 19, 2014 4.449
Aug. 18, 2014 4.439
Aug. 15, 2014 4.244
Aug. 14, 2014 4.128
Aug. 13, 2014 4.092
Aug. 12, 2014 3.966
Aug. 11, 2014 4.074
Aug. 8, 2014 4.059
Aug. 7, 2014 4.076
Aug. 6, 2014 4.014
Aug. 5, 2014 4.090
Aug. 4, 2014 4.251
Aug. 1, 2014 4.110
July 31, 2014 4.047
July 30, 2014 4.302
July 29, 2014 4.256
July 28, 2014 4.100
July 25, 2014 4.282
July 24, 2014 4.450
July 23, 2014 4.285

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Price to Book Ratio

Price to book value is a financial ratio used to compare a company's book value to its current market price. Book value is an accounting term denoting the portion of the company held by the shareholders at accounting value (not market value). In other words, book value is the company's total tangible assets less its total liabilities.

The ratio has two calculation methods. In the first way, the company's market capitalization is divided by the company's total book value from its balance sheet. The second way, using per-share values, is to divide the company's current share price by the book value per share. In general, a low price to book value indicates that a stock is undervalued and thus more desirable.

In theory, if you purchased stock with a price to book value less than 1 and the company immediately went bankrupt, you would gain money on your investment. In reality, this may not be true since there are times when liquidation value, or the price at which a company's assets can be sold, is less than the book value of those assets.

For more information on evaluating valuation multiples similar to this, please see our original white paper research : Making Sense Of Valuation Multiples.
Learn More

Get data for
Advertisement

GEVA Price to Book Value Benchmarks

Companies
Agios Pharmaceuticals 10.53
Acorda Therapeutics 2.826
Celladon 3.992

GEVA Price to Book Value Range, Past 5 Years

Minimum 0.7259 Sep 12 2011
Maximum 10.47 Mar 27 2012
Average 3.877

GEVA Price to Book Value Excel Add-In Codes

  • Metric Code: price_to_book_value
  • Latest data point: =YCP("GEVA", "price_to_book_value")
  • Last 5 data points: =YCS("GEVA", "price_to_book_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts Professional.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.